Asprosin and meteorin-like protein immunoreactivity in invasive ductal breast carcinoma stages

Asprosin and meteorin-like protein immunoreactivity in invasive ductal breast carcinoma stages

The study aimed to investigate asprosin (ASP) and meteorin-like (METRNL) protein immunoreactivity in invasive ductal breast cancer. Overall, 60 cases of invasive ductal breast cancer (20 cases each of Grade 1, 2 and 3) were evaluated in addition to 20 normal breast tissues obtained from the Patholog...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tissue & cell 2022-08, Vol.77, p.101855-101855, Article 101855
Hauptverfasser: Akkus, Gulsum, Koyuturk, Leyla Canpolat, Yilmaz, Mustafa, Hancer, Serhat, Ozercan, Ibrahim Hanifi, Kuloglu, Tuncay
Format: Artikel
Sprache:eng
Schlagworte:
Asprosin
Histopathology
Invasive ductal breast cancer
Meteorin-like protein
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The study aimed to investigate asprosin (ASP) and meteorin-like (METRNL) protein immunoreactivity in invasive ductal breast cancer. Overall, 60 cases of invasive ductal breast cancer (20 cases each of Grade 1, 2 and 3) were evaluated in addition to 20 normal breast tissues obtained from the Pathology Department Archive. ASP and METRNL expressions were assessed using immunohistochemical staining and visualised under a light microscope. There was a significant difference in ASP and METRNL immunoreactivity among all the groups included in the study (p 
ISSN:0040-8166
1532-3072
DOI:10.1016/j.tice.2022.101855